GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PT Indofarma Tbk (ISX:INAF) » Definitions » Cyclically Adjusted PB Ratio

PT Indofarma Tbk (ISX:INAF) Cyclically Adjusted PB Ratio : 0.87 (As of Jun. 12, 2024)


View and export this data going back to 2001. Start your Free Trial

What is PT Indofarma Tbk Cyclically Adjusted PB Ratio?

As of today (2024-06-12), PT Indofarma Tbk's current share price is Rp153.00. PT Indofarma Tbk's Cyclically Adjusted Book per Share for the quarter that ended in Sep. 2023 was Rp176.28. PT Indofarma Tbk's Cyclically Adjusted PB Ratio for today is 0.87.

The historical rank and industry rank for PT Indofarma Tbk's Cyclically Adjusted PB Ratio or its related term are showing as below:

ISX:INAF' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.74   Med: 5.08   Max: 27.31
Current: 0.92

During the past years, PT Indofarma Tbk's highest Cyclically Adjusted PB Ratio was 27.31. The lowest was 0.74. And the median was 5.08.

ISX:INAF's Cyclically Adjusted PB Ratio is ranked better than
75.3% of 749 companies
in the Drug Manufacturers industry
Industry Median: 1.89 vs ISX:INAF: 0.92

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

PT Indofarma Tbk's adjusted book value per share data for the three months ended in Sep. 2023 was Rp-33.989. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is Rp176.28 for the trailing ten years ended in Sep. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


PT Indofarma Tbk Cyclically Adjusted PB Ratio Historical Data

The historical data trend for PT Indofarma Tbk's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Indofarma Tbk Cyclically Adjusted PB Ratio Chart

PT Indofarma Tbk Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 4.23 19.48 10.79 5.78

PT Indofarma Tbk Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.80 5.78 3.72 3.41 2.78

Competitive Comparison of PT Indofarma Tbk's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, PT Indofarma Tbk's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Indofarma Tbk's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PT Indofarma Tbk's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where PT Indofarma Tbk's Cyclically Adjusted PB Ratio falls into.



PT Indofarma Tbk Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

PT Indofarma Tbk's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=153.00/176.28
=0.87

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Indofarma Tbk's Cyclically Adjusted Book per Share for the quarter that ended in Sep. 2023 is calculated as:

For example, PT Indofarma Tbk's adjusted Book Value per Share data for the three months ended in Sep. 2023 was:

Adj_Book=Book Value per Share/CPI of Sep. 2023 (Change)*Current CPI (Sep. 2023)
=-33.989/128.1514*128.1514
=-33.989

Current CPI (Sep. 2023) = 128.1514.

PT Indofarma Tbk Quarterly Data

Book Value per Share CPI Adj_Book
201309 188.656 90.474 267.221
201312 187.604 91.196 263.626
201403 178.238 92.483 246.979
201406 174.199 93.015 240.003
201409 179.113 94.576 242.700
201412 189.624 98.819 245.909
201503 184.564 98.388 240.398
201506 183.318 99.766 235.475
201509 180.683 101.037 229.172
201512 191.240 102.133 239.959
201603 184.924 102.764 230.609
201606 182.249 103.212 226.286
201609 181.429 104.142 223.256
201612 185.771 105.222 226.253
201703 174.532 106.476 210.062
201709 0.000 108.020 0.000
201712 169.849 109.017 199.661
201803 0.000 110.097 0.000
201806 0.000 111.085 0.000
201809 158.526 111.135 182.799
201812 160.246 112.430 182.654
201903 153.221 112.829 174.029
201906 152.387 114.730 170.213
201909 149.004 114.905 166.182
201912 162.920 115.486 180.788
202003 155.893 116.252 171.850
202006 161.416 116.630 177.362
202009 156.828 116.397 172.666
202012 138.846 117.318 151.667
202103 139.433 117.840 151.634
202106 139.162 118.184 150.899
202109 139.758 118.262 151.445
202112 164.005 119.516 175.855
202203 147.491 120.948 156.275
202206 134.735 123.322 140.011
202209 104.923 125.298 107.312
202212 27.864 126.098 28.318
202303 7.925 126.953 8.000
202306 -10.966 127.663 -11.008
202309 -33.989 128.151 -33.989

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


PT Indofarma Tbk  (ISX:INAF) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


PT Indofarma Tbk Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of PT Indofarma Tbk's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


PT Indofarma Tbk (ISX:INAF) Business Description

Traded in Other Exchanges
N/A
Address
Jalan Indofarma No. 1, Cikarang Barat, Jawa Bara, Bekasi, IDN, 17530
PT Indofarma Tbk is a specialty and generic drug manufacturing company. The company has four business segments - Medicine, Medical Devices and others, Pharmaceutical Engineering, and Aliansi Strategis Segment. The Medicine business segment includes drug production, marketing and distribution and sales. The Medical Device Segment includes medical devices and other products. The Pharmaceutical Engineering Segment includes the sale and maintenance of packaging machines for the pharmaceutical industry to external parties.

PT Indofarma Tbk (ISX:INAF) Headlines

No Headlines